Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Clinicopathologic and Prognostic Significance of Carboxyl Terminus of Hsp70-interacting Protein in HBV-related Hepatocellular Carcinoma

  • Jin, Ye (Clinical Research Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College) ;
  • Zhou, Li (Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College) ;
  • Liang, Zhi-Yong (Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College) ;
  • Jin, Ke-Min (Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Department of Hepatobiliary Surgery I, Peking University School of Oncology, Beijing Cancer Hospital & Institute) ;
  • Zhou, Wei-Xun (Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College) ;
  • Xing, Bao-Cai (Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Department of Hepatobiliary Surgery I, Peking University School of Oncology, Beijing Cancer Hospital & Institute)
  • Published : 2015.05.18
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Many factors, including molecular ones, were demonstrated to be associated with long-term prognosis of hepatocellular carcinoma (HCC). Thus far, the expression and clinicopathologic and prognostic significance of the carboxyl terminus of Hsp70-interacting protein (CHIP) in B-type hepatitis virus (HBV)-related HCC remain unknown. Materials and Methods: CHIP expression was detected by immunohistochemical staining of surgical samples from 79 patients with HCC with HBsAg positivity. In addition, correlations with clinicopathologic parameters and patient survival were evaluated. Results: It was found that positive CHIP staining was observed in tumor, but not non-tumor, tissues. High expression of CHIP was significantly related to larger tumor size, with marginally significant associations noted for presence of portal vein invasion and higher serum a-fetoprotein level. In addition, univariate analysis showed that high CHIP expression was a powerful predictor for dismal overall and disease-free survival. However, independent prognostic implications of CHIP were not proven in multivariate Cox regression test. Conclusions: CHIP is overexpressed in HBV-related HCC and is associated with unfavorable biological behavior as well as poor prognosis. However, its prognostic role needs to be further validated.

Keywords

References

  1. Ballinger CA, Connell P, Wu Y, et al (1999). Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol, 19, 4535-45. https://doi.org/10.1128/MCB.19.6.4535
  2. Choi KK, Kim SH, Choi SB, et al (2011). Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma. J Gastroenterol Hepatol, 26, 1646-51. https://doi.org/10.1111/j.1440-1746.2011.06780.x
  3. Connell P, Ballinger CA, Jiang J, et al (2001). The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol, 3, 93-6. https://doi.org/10.1038/35050618
  4. Edmondson HA, Steiner PE (1954). Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer, 7, 462-503. https://doi.org/10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E
  5. Effendi K, Sakamoto M (2010). Molecular pathology in early hepatocarcinogenesis. Oncology, 78, 157-60. https://doi.org/10.1159/000312658
  6. El-Serag HB (2011). Hepatocellular carcinoma. N Engl J Med, 365, 1118-27. https://doi.org/10.1056/NEJMra1001683
  7. Jan CI, Yu CC, Hung MC, et al (2011). Tid1, CHIP and ErbB2 interactions and their prognostic implications for breast cancer patients. J Pathol, 225, 424-37. https://doi.org/10.1002/path.2921
  8. Jang KW, Lee KH, Kim SH, et al (2011). Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-${\kappa}B$ inactivation to regulate breast cancer cell invasion. J Cell Biochem, 112, 3612-20. https://doi.org/10.1002/jcb.23292
  9. Kaibori M, Ishizaki M, Matsui K, Kwon AH (2010). Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J Surg Oncol, 102, 462-8. https://doi.org/10.1002/jso.21631
  10. Kim SJ, Lee KK, Kim DG (2010). Tumor size predicts the biological behavior and influence of operative modalities in hepatocellular carcinoma. Hepatogastroenterology, 57, 121-6.
  11. Liang ZL, Kim M, Huang SM, Lee HJ, Kim JM (2013). Expression of carboxyl terminus of Hsp70-interacting protein (CHIP) indicates poor prognosis in human gallbladder carcinoma. Oncol Lett, 5, 813-8.
  12. Minguez B, Lachenmayer A (2011). Diagnostic and prognostic molecular markers in hepatocellular carcinoma. Dis Markers, 31, 181-90. https://doi.org/10.1155/2011/310675
  13. Peng SY, Chen WJ, Lai PL, et al (2004). High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer, 112, 44-50. https://doi.org/10.1002/ijc.20279
  14. Parkin DM, Pisani P, Ferlay J (1993). Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer, 54, 594-606. https://doi.org/10.1002/ijc.2910540413
  15. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  16. Pisani P, Parkin DM, Bray F, Ferlay J (1999). Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 83, 18-29. https://doi.org/10.1002/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M
  17. Poon RT, Fan ST, Lo CM, et al (2001). Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg, 234, 63-70. https://doi.org/10.1097/00000658-200107000-00010
  18. Sarkar S, Brautigan DL, Parsons SJ, Larner JM (2014). Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells. Oncogene, 33, 26-33. https://doi.org/10.1038/onc.2012.561
  19. Shimozawa N, Hanazaki K (2004). Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg, 198, 356-65. https://doi.org/10.1016/j.jamcollsurg.2003.10.017
  20. Tandon P, Garcia-Tsao G (2009). Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int 29, 502-10. https://doi.org/10.1111/j.1478-3231.2008.01957.x
  21. Verhoef C, de Man RA, Zondervan PE, et al (2004). Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver. Dig Surg, 21, 380-6. https://doi.org/10.1159/000081882
  22. Wang S, Wu X, Zhang J, et al (2013). CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer. Gut, 62, 496-508. https://doi.org/10.1136/gutjnl-2011-301522
  23. Wang T, Yang J, Xu J, et al (2014). CHIP is a novel tumor suppressor in pancreatic cancer through targeting EGFR. Oncotarget, 5, 1969-86. https://doi.org/10.18632/oncotarget.1890
  24. Wen J, Luo KJ, Hu Y, Yang H, Fu JH (2013). Metastatic lymph node CHIP expression is a potential prognostic marker for resected esophageal squamous cell carcinoma patients. Ann Surg Oncol, 20, 1668-75. https://doi.org/10.1245/s10434-012-2733-4
  25. Xu T, Zhou Q, Zhou J, et al (2011). Carboxyl terminus of Hsp70-interacting protein (CHIP) contributes to human glioma oncogenesis. Cancer Sci, 102, 959-66. https://doi.org/10.1111/j.1349-7006.2011.01888.x